Back to Search
MICHAEL TOMASSON, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1841216157IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
MD-43803(IA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.
PMID 19135901·Exp Hematol·2009
8-other
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
PMID 19029964·Bone Marrow Transplant·2009
3-trial
Recurring mutations found by sequencing an acute myeloid leukemia genome.
PMID 19657110·N Engl J Med·2009
5-case
Acquired copy number alterations in adult acute myeloid leukemia genomes.
PMID 19651600·Proc Natl Acad Sci U S A·2009
8-other
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
PMID 18987736·Nature·2008
8-other
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.
PMID 18160671·Blood·2008
7-preclinical
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
PMID 18292815·J Clin Invest·2008
7-preclinical
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
PMID 18270328·Blood·2008
8-other
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes.
PMID 18216297·Blood·2008
7-preclinical
Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.
PMID 17060458·Mol Cell Biol·2007
7-preclinical
Bortezomib inhibits osteoclast activity in patients with multiple myeloma.
PMID 18186967·Clin Lymphoma Myeloma·2007
3-trial
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
PMID 17889357·Biol Blood Marrow Transplant·2007
3-trial
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
PMID 17494858·Blood·2007
3-trial
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
PMID 17218386·Blood·2007
7-preclinical
The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
PMID 17043015·Haematologica·2006
8-other
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
PMID 16025152·Bone Marrow Transplant·2005
4-observational
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
PMID 15972450·Blood·2005
7-preclinical
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
PMID 15258562·Bone Marrow Transplant·2004
8-other
Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657.
PMID 15044254·Blood·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 HAWKINS DR, DEPT OF INTERNAL MEDICINE
IOWA CITY, IA 52242 - Phone
- (319) 335-4958
Quick Facts
- NPI
- 1841216157
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile